Lake Street lowered the firm’s price target on Tela Bio (TELA) to $2 from $3 and keeps a Buy rating on the shares following an “approximately in line” Q4 and reset of 2026 guidance. The company now guides to 8% top line growth, versus the previous 15% growth expectation introduced with Q3 results, notes the analyst, who says shares “remain in show me territory.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TELA:
